Matthew Myntti
Founder bei NEXT SCIENCE LIMITED
Vermögen: 2 Mio $ am 31.03.2024
Profil
Matthew Myntti is the founder of Next Science Ltd.
which was founded in 2017, where he holds the title of Chief Technology Officer.
He is currently a Director at Microbial Defense System Holdings, Inc. since 2012.
He previously worked at Synthes GmbH as the President-Asia Pacific.
Dr. Myntti received his undergraduate and doctorate degrees from the University of Dayton.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
NEXT SCIENCE LTD
3,59% | 14.03.2023 | 10 472 969 ( 3,59% ) | 2 Mio $ | 31.03.2024 |
Aktive Positionen von Matthew Myntti
| Unternehmen | Position | Beginn |
|---|---|---|
| NEXT SCIENCE LIMITED | Founder | 20.10.2017 |
Microbial Defense System Holdings, Inc.
 Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Microbial Defense System Holdings, Inc. provides investment advice. The company is headquartered in Wilmington, DE. | Director/Board Member | 30.03.2012 |
Ehemalige bekannte Positionen von Matthew Myntti
| Unternehmen | Position | Ende |
|---|---|---|
Synthes GmbH
 Synthes GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Synthes GmbH is a German company that manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery. The private company is based in Umkirch, Germany. The company was founded in 2002. The CEO is Ulrich Jäggle. | Corporate Officer/Principal | - |
Ausbildung von Matthew Myntti
| University of Dayton | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| NEXT SCIENCE LIMITED | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Synthes GmbH
Synthes GmbH Medical SpecialtiesHealth Technology Part of Johnson & Johnson, Synthes GmbH is a German company that manufactures and distributes healthcare equipment for traumatology, orthopaedy, oral and maxillofacial surgery, and neurosurgery. The private company is based in Umkirch, Germany. The company was founded in 2002. The CEO is Ulrich Jäggle. | Health Technology |
Microbial Defense System Holdings, Inc.
Microbial Defense System Holdings, Inc. Financial ConglomeratesFinance Microbial Defense System Holdings, Inc. provides investment advice. The company is headquartered in Wilmington, DE. | Finance |
